BARD1 and ovarian cancer: The Cys557Ser missense variant was identified within the BARD1 region that was required to regulate apoptosis and transcriptional machinery and revealed higher frequency in the breast, but not ovarian cancer cases compared to healthy controls (7.4 vs 1.4%, p = 0.001).